Clinical Trial Update: A First-in-human Clinical Trial Using a Gene Therapy With Patient's Own Stem Cells to Treat Early Type 1 Diabetes [Phase 1, Phase 2]

View source ↗

Summary

A first-in-human phase 1/2 clinical trial evaluates an autologous stem cell–based gene therapy to treat early Type 1 diabetes; the study is sponsored by Altheia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Autologous stem cell gene therapy (investigational)

Snippet

Sponsor: Altheia Science | Conditions: Diabetes, Type I | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING